“Pfizer-BioNTech is postponing its rolling application to the Food and Drug Administration to expand the use of its two-dose Covid-19 vaccine for children ages 6 months to 4 years,” NBC News reports.
“The move means that vaccines for this age group will not be available in the coming weeks, a setback for parents eager to vaccinate their young children.”
Save to Favorites